Currently, synthetic biology has evolved from a frontier laboratory exploration into a core battleground for national strategic competition. The 2026 Government Work Report explicitly calls for cultivating and expanding emerging industries and future industries, promoting biomanufacturing as a new economic growth driver. This means that synthetic biology and biomanufacturing are no longer merely technical issues; they have become a strategic convergence point bearing threefold missions: national security (supply chain self-sufficiency), climate agenda (dual carbon / net-zero carbon goals), and economic growth (new quality productive forces).
This White Book will cover the strategic definition and industrial significance of synthetic biology, key technology evolution and innovation breakthroughs, panoramic mapping of the industry chain and value chain decomposition, global country and regional benchmarking with regulatory frameworks, financing logic, core challenges, and future trends. It establishes a research framework that transcends single-region perspectives, integrating global depth and full-industry-chain coverage. Through in-depth analysis of core markets in China, the United States, the European Union, the Middle East, and key Belt and Road Initiative countries, combined with systematic comparisons of cross-border regulatory policies, and applying a triple analytical lens—industry chain panorama, country/regional benchmarking, and regulation-technology-business assessment—it effectively avoids common cognitive biases in the industry. The result provides enterprise strategists and investment institutions with deep insights that offer cross-regional comparative value and industrial reference significance.
